ResMed (RMD) shares are pushing higher on Tuesday after a senior RBC Capital Markets ****** yst upgraded the medical equipment specialist to an "Outperform" rating. In his research note, Craig Wong-Pan cited RMD's robust Q4 performance as he lifted his price target as well to $262, indicating potential upside of nearly 10% from here.
Note that ResMed stock has already been in a massive uptrend in recent months, currently trading about 28% above its June low.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
1 'Strong Buy' Dividend Stock Offering a 6.3% Yield Right Now
#markets
Note that ResMed stock has already been in a massive uptrend in recent months, currently trading about 28% above its June low.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
1 'Strong Buy' Dividend Stock Offering a 6.3% Yield Right Now
#markets
2 months ago
